Untreated Adult Acute Myeloid Leukemia Completed Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01168219Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid LeukemiaTreatment